MMEN.CN stock jumps 33% to C$0.02 on heavy volume: what traders should watch next

MMEN.CN stock rose sharply in Canada market hours, trading up 33.33% to C$0.02 on volume of 189,038 shares. We note a move from the day low C$0.015 and a day high C$0.02, with market cap about C$27,664,000 and shares outstanding 1,383,200,000. The move follows thin liquidity and headline sensitivity for MedMen Enterprises Inc. (MMEN.CN) on the CNQ exchange. We summarise drivers, valuation, risks, and the Meyka AI forecast to help investors see the tradeoffs.

MMEN.CN stock: Market move and intraday picture

MedMen Enterprises Inc. (MMEN.CN) widened intraday after opening at C$0.015 and closing the high at C$0.02. Trading volume 189,038 is above the 50-day average volume of 145,639, which signals higher participation today.

Price momentum is concentrated near the 50-day average C$0.0231 and below the 200-day average C$0.02665, indicating the stock is still below medium-term averages despite the gain. Short-term volatility is high with a one-day change of 33.33%.

MMEN.CN stock: Fundamentals and valuation

MedMen reports trailing EPS of -0.15 and a negative P/E reflecting losses. The company shows a low price-to-sales of 0.14 and price-to-book near 0.11, but high leverage with debt-to-equity 2.61.

Current metrics show weak liquidity with a current ratio of 0.49 and cash per share of 0.01 CAD. Those numbers frame why upside requires operational improvement or capital restructuring.

MMEN.CN stock: Technical setup and momentum signals

Technically, MMEN.CN traded above the previous close C$0.015 and remains below the 50-day and 200-day averages. The relative volume of 1.30 suggests today’s move has conviction from active traders.

Given a year high of C$0.05 and year low C$0.015, short-term traders may watch C$0.02 as support or resistance on next tests.

MMEN.CN stock: Sector context and risk factors

MedMen operates in the Healthcare sector under Drug Manufacturers – Specialty & Generic, but its business is cannabis retail. The sector average metrics differ from MedMen’s; peers typically show higher current ratios and lower debt-to-equity, increasing relative risk for MMEN.CN.

Key risks include continued negative margins, high debt, and thin market liquidity. Regulatory shifts or US state-level cannabis policy could quickly change sentiment either way.

MMEN.CN stock: Meyka grade, forecast and analyst view

Meyka AI rates MMEN.CN with a score out of 100: 60.34 / B — HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. The score reflects mixed fundamentals, elevated leverage, and volatile trading.

Meyka AI’s forecast model projects a 12-month base-case price of C$0.04, an implied upside of 100.00% from the current C$0.02. We also model a conservative target of C$0.03 (+50.00%) and an optimistic recovery target of C$0.06 (+200.00%). Forecasts are model-based projections and not guarantees.

Final Thoughts

MMEN.CN stock’s intraday jump to C$0.02 on 18 Feb 2026 highlights how thin liquidity and news sensitivity can produce sharp moves. The company posts trailing EPS -0.15, negative margins, and a high debt-to-equity of 2.61, so fundamentals currently lag sector norms in Healthcare and specialty drug retail. Traders should weigh the higher short-term volatility against the potential for recovery if MedMen improves cash flow or reduces leverage. Meyka AI’s model gives a 12-month base-case of C$0.04, implying 100.00% upside from today’s price, with conservative and optimistic targets at C$0.03 and C$0.06 respectively. These forecasts assume successful operational changes or new capital and are not guarantees. We recommend monitoring liquidity, upcoming earnings, and any corporate funding updates before increasing exposure. Meyka AI, our AI-powered market analysis platform, will update grades and forecasts as new filings and trading data arrive.

FAQs

What drove the MMEN.CN stock gain today?

MMEN.CN stock rose on higher-than-average volume 189,038 and short-term buying pressure. The move reflects thin liquidity and trader attention rather than a clear earnings beat or major filing.

What is Meyka AI’s price forecast for MMEN.CN stock?

Meyka AI’s forecast model projects a 12-month base-case price of C$0.04 for MMEN.CN stock, implying 100.00% upside from the current C$0.02. Forecasts are model-based projections and not guarantees.

Is MMEN.CN stock a value play or high risk?

MMEN.CN shows low valuation ratios like price-to-book 0.11, but high leverage and negative margins make it a high-risk speculative investment rather than a traditional value play.

Which metrics should investors watch for MMEN.CN stock?

Watch liquidity and leverage: current ratio 0.49, debt-to-equity 2.61, cash per share 0.01 CAD, and upcoming earnings announcements or capital raises that affect runway and valuation.

Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.